HALOPERIDOL Side Effects

6822077-6 | Agitation, Mental Status Changes, Unresponsive To Stimuli
on Jul 06, 2010 Male patient from UNITED STATES , 86 years of age, was diagnosed with abnormal behaviour, dementia (What is dementia?) and was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, mental status changes, unresponsive to stimuli. Haloperidol dosage: 2 Mg Once Po.

6809687-7 | Bradykinesia, Catatonia, Cogwheel Rigidity, Parkinsonian Gait, Salivary Hypersecretion, Seborrhoea, Tremor
Patient was taking Haloperidol (View Usage). Patient had the following side effects: bradykinesia, catatonia, cogwheel rigidity, parkinsonian gait, salivary hypersecretion, seborrhoea, tremor on Feb 10, 2010 from AUSTRALIA Additional patient health information: Female patient , 32 years of age, was diagnosed with mania and. Haloperidol dosage: . During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ).

6809297-1 | Bradykinesia, Catatonia, Cogwheel Rigidity, Parkinsonian Gait
Adverse event was reported on Feb 10, 2010 by a Female patient taking Haloperidol (View Usage) (Dosage: ) was diagnosed with mania and. Location: AUSTRALIA , 25 years of age, After Haloperidol was administered, patient had the following side effects: bradykinesia, catatonia, cogwheel rigidity, parkinsonian gait. During the same period patient was treated with LITHIUM CORBONATE (View Lithium Corbonate Review and Lithium Corbonate Label ), BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ), CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ).

6809294-6 | Catatonia, Cogwheel Rigidity, Parkinsonian Gait
on Feb 10, 2010 Male patient from AUSTRALIA , 59 years of age, was diagnosed with mania and was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: catatonia, cogwheel rigidity, parkinsonian gait. Haloperidol dosage: . During the same period patient was treated with LITHIUM CORBONATE (View Lithium Corbonate Review and Lithium Corbonate Label ), CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ).


6809288-0 | Bradykinesia, Catatonia, Parkinsonian Gait, Salivary Hypersecretion, Seborrhoea
on Feb 10, 2010 Female patient from AUSTRALIA , 22 years of age, was diagnosed with schizophrenia and was treated with Haloperidol (View Usage). Patient had the following side effects: bradykinesia, catatonia, parkinsonian gait, salivary hypersecretion, seborrhoea. Haloperidol dosage: . During the same period patient was treated with CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ).

6809287-9 | Catatonia, Cogwheel Rigidity, Parkinsonian Gait
Patient was taking Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: catatonia, cogwheel rigidity, parkinsonian gait on Feb 10, 2010 from AUSTRALIA Additional patient health information: Female patient , 34 years of age, was diagnosed with mania and. Haloperidol dosage: . During the same period patient was treated with LITHIUM CORBONATE (View Lithium Corbonate Review and Lithium Corbonate Label ).

6809281-8 | Catatonia, Cogwheel Rigidity, Seborrhoea
Adverse event was reported on Feb 10, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: ) was diagnosed with mania and. Location: AUSTRALIA , 18 years of age, Patient experienced the following unwanted or unexpected effects: catatonia, cogwheel rigidity, seborrhoea. During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ).

6803538-2 | Catatonia, Cogwheel Rigidity, Parkinsonian Gait, Tremor
on Feb 10, 2010 Female patient from AUSTRALIA , 73 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Haloperidol (View Usage). Patient had the following side effects: catatonia, cogwheel rigidity, parkinsonian gait, tremor. Haloperidol dosage: . During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), TRIFLUOPERAZINE (View Trifluoperazine Review and Trifluoperazine Label ).

6803529-1 | Bradykinesia, Catatonia, Cogwheel Rigidity, Parkinsonian Gait, Tremor
on Feb 10, 2010 Male patient from AUSTRALIA , 49 years of age, was treated with Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: bradykinesia, catatonia, cogwheel rigidity, parkinsonian gait, tremor. Haloperidol dosage: . During the same period patient was treated with THIORIDAZINE HCL (View Thioridazine Hcl Review and Thioridazine Hcl Label ).

6803037-8 | Bradykinesia, Catatonia, Cogwheel Rigidity, Parkinsonian Gait, Salivary Hypersecretion
Patient was taking Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: bradykinesia, catatonia, cogwheel rigidity, parkinsonian gait, salivary hypersecretion on Feb 10, 2010 from AUSTRALIA Additional patient health information: Male patient , 47 years of age, . Haloperidol dosage: . During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ).

6790112-X | Hypersensitivity, Muscle Rigidity, Neuroleptic Malignant Syndrome, Pyrexia, Somnolence
Adverse event was reported on Jun 16, 2010 by a Female patient taking Haloperidol (View Usage) (Dosage: ) was diagnosed with agitation and. Location: UNITED KINGDOM , 67 years of age, Patient had the following side effects: hypersensitivity, muscle rigidity, neuroleptic malignant syndrome, pyrexia, somnolence. During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), BUSCOPAN (View Buscopan Review and Buscopan Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), NULYTELY (View Nulytely Review and Nulytely Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), SINEMET (View Sinemet Review and Sinemet Label ), GALANTAMINE (View Galantamine Review and Galantamine Label ). Patient was hospitalized.

6774893-7 | Akathisia, Emotional Distress, Hypertension, Irritability
on Jun 16, 2010 Male patient from UNITED STATES , 45 years of age, weighting 248.0 lb, was diagnosed with mania and was treated with Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: akathisia, emotional distress, hypertension, irritability. Haloperidol dosage: Haldol Dec Given Once Im.

6765433-7 | Agitation, Anxiety, Chest Pain, Deep Vein Thrombosis, Fear, Hyperventilation, Hypophagia, Pulmonary Embolism, Syncope
on Jun 02, 2010 Male patient from SWEDEN , 27 years of age, weighting 176.4 lb, was diagnosed with agitation, acute psychosis and was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, anxiety (What is anxiety?), chest pain (What is chest pain?), deep vein thrombosis (What is deep vein thrombosis?), fear, hyperventilation, hypophagia, pulmonary embolism (What is pulmonary embolism?), syncope. Haloperidol dosage: 2 Mg+5 Mg. During the same period patient was treated with ZUCLOPENTHIXOL (View Zuclopenthixol Review and Zuclopenthixol Label ), CHLORPROTHIXENE (View Chlorprothixene Review and Chlorprothixene Label ). Patient was hospitalized.

6763969-6 | Acute Hepatic Failure
Patient was taking Haloperidol (View Usage). Patient had the following side effects: acute hepatic failure on Jun 07, 2010 from GERMANY Additional patient health information: Female patient , 64 years of age, was diagnosed with prophylaxis and. Haloperidol dosage: . During the same period patient was treated with EUNERPAN (View Eunerpan Review and Eunerpan Label ), VITAMIN B1 TAB (View Vitamin B1 Tab Review and Vitamin B1 Tab Label ).

6763302-X | Akathisia, Dystonia
Adverse event was reported on Jun 01, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: ) . Location: UNITED STATES , 13 years of age, weighting 154.3 lb, After Haloperidol was administered, patient had the following side effects: akathisia, dystonia (What is dystonia?). During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ). Patient was hospitalized.

6763250-5 | Depressed Level Of Consciousness, Dysphagia, Feeling Abnormal, Movement Disorder, Pneumonia Aspiration
on Jun 08, 2010 Male patient from UNITED STATES , 92 years of age, weighting 150.0 lb, was diagnosed with abnormal behaviour, dementia (What is dementia?) and was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, dysphagia, feeling abnormal, movement disorder (What is movement disorder?), pneumonia aspiration. Haloperidol dosage: 1 Mg Every 4 Hours Iv. During the same period patient was treated with IV NORMAL SALINE (View Iv Normal Saline Review and Iv Normal Saline Label ), IV PROTONICS (View Iv Protonics Review and Iv Protonics Label ), IV VANCOMYCIN/ZOSYN (View Iv Vancomycin/zosyn Review and Iv Vancomycin/zosyn Label ).

6760557-2 | Nausea, Neuroleptic Malignant Syndrome, Pyrexia, Viral Infection
on Jun 07, 2010 Male patient from UNITED STATES , 28 years of age, weighting 150.0 lb, was treated with Haloperidol (View Usage). Patient had the following side effects: nausea (What is nausea?), neuroleptic malignant syndrome, pyrexia, viral infection (What is viral infection?). Haloperidol dosage: 20 Mg Daily. Patient was hospitalized.

6759817-0 | Venous Thrombosis
Patient was taking Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: venous thrombosis on Jun 02, 2010 from SWEDEN Additional patient health information: Male patient , 27 years of age, . Haloperidol dosage: . During the same period patient was treated with ZUCLOPENTHIXOL (View Zuclopenthixol Review and Zuclopenthixol Label ), CHLORPROTHIXENE (View Chlorprothixene Review and Chlorprothixene Label ), BENZODIAZEPINE NOS (View Benzodiazepine Nos Review and Benzodiazepine Nos Label ).

6743995-3 | Myocardial Infarction, Pulmonary Embolism, Venous Thrombosis
Adverse event was reported on May 04, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: ) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: SWEDEN , 59 years of age, Patient experienced the following unwanted or unexpected effects: myocardial infarction, pulmonary embolism (What is pulmonary embolism?), venous thrombosis. During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ).

6743694-8 | Pulmonary Embolism
on May 04, 2010 Male patient from SWEDEN , 37 years of age, was treated with Haloperidol (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Haloperidol dosage: . During the same period patient was treated with OLANZAPINE (View Olanzapine Review and Olanzapine Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ).

6743595-5 | Venous Thrombosis
on May 04, 2010 Male patient from SWEDEN , 27 years of age, was treated with Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: venous thrombosis. Haloperidol dosage: . During the same period patient was treated with ZUCLOPENTHIXOL (View Zuclopenthixol Review and Zuclopenthixol Label ), CHLORPROTHIXENE (View Chlorprothixene Review and Chlorprothixene Label ), BENZODIAZEPINE NOS (View Benzodiazepine Nos Review and Benzodiazepine Nos Label ).

6737388-2 | Blood Creatinine Increased, Infection, Labile Blood Pressure, Neuroleptic Malignant Syndrome, Pyrexia
Patient was taking Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, infection (What is infection?), labile blood pressure, neuroleptic malignant syndrome, pyrexia on May 20, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 45 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?), agitation and. Haloperidol dosage: . During the same period patient was treated with OLANZAPINE (View Olanzapine Review and Olanzapine Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ). Patient was hospitalized.

6735126-0 | Malaise, Tardive Dyskinesia
Adverse event was reported on May 20, 2010 by a Female patient taking Haloperidol (View Usage) (Dosage: 0.5 Mg 4 A Day At One Time Was Taking 5 A Day Oral) was diagnosed with depression (What is depression?) and. Location: UNITED STATES , weighting 140.0 lb, Patient had the following side effects: malaise, tardive dyskinesia. Patient was hospitalized and became disabled.

6732152-2 | Grand Mal Convulsion, Hypertension, Hyponatraemia, Loss Of Consciousness, Polydipsia, Polyuria
on Aug 10, 2009 Male patient from KOREA, REPUBLIC OF , 39 years of age, was diagnosed with schizophrenia and was treated with Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: grand mal convulsion, hypertension, hyponatraemia, loss of consciousness, polydipsia, polyuria. Haloperidol dosage: .

6731645-1 | Chorea
on May 04, 2010 Female patient from SLOVAKIA (Slovak Republic) , 60 years of age, was diagnosed with schizoaffective disorder and was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: chorea. Haloperidol dosage: . During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ).

6731638-4 | Suicide Attempt
Patient was taking Haloperidol (View Usage). Patient had the following side effects: suicide attempt on May 04, 2010 from ITALY Additional patient health information: Female patient , 16 years of age, . Haloperidol dosage: .

6731355-0 | Neuroleptic Malignant Syndrome
Adverse event was reported on May 17, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: 100 Mg Q4w Im) . Location: UNITED STATES , 41 years of age, weighting 200.0 lb, After Haloperidol was administered, patient had the following side effects: neuroleptic malignant syndrome. During the same period patient was treated with SEROQUEL (100 Mg Hs Po) (View Seroquel Review and Seroquel Label ).

6731260-X | Tardive Dyskinesia
on May 17, 2010 Male patient from UNITED STATES , 30 years of age, weighting 180.0 lb, was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: tardive dyskinesia. Haloperidol dosage: 100mg Q4w Im.

6725703-5 | Aggression, Catatonia, Dysphagia, Hypernatraemia, Moaning, Nausea, Neuroleptic Malignant Syndrome, No Therapeutic Response, Pneumonia Aspiration
on May 13, 2010 Female patient from UNITED STATES , weighting 125.7 lb, was diagnosed with aggression, bipolar disorder (What is bipolar disorder?) and was treated with Haloperidol (View Usage). Patient had the following side effects: aggression, catatonia, dysphagia, hypernatraemia, moaning, nausea (What is nausea?), neuroleptic malignant syndrome, no therapeutic response, pneumonia aspiration. Haloperidol dosage: Po. During the same period patient was treated with LITHIUM (300 Mg Four Times Daily Po) (View Lithium Review and Lithium Label ), IMODIUM (View Imodium Review and Imodium Label ), AMBIEN (View Ambien Review and Ambien Label ), BROMOCRIPTINE (View Bromocriptine Review and Bromocriptine Label ), DANTROLENE (View Dantrolene Review and Dantrolene Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ). Patient was hospitalized.

6724236-X | Brief Psychotic Disorder, With Postpartum Onset
Patient was taking Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: brief psychotic disorder, with postpartum onset on May 13, 2010 from UNITED STATES Additional patient health information: Female patient , 35 years of age, . Haloperidol dosage: . During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ). Patient was hospitalized.

6716438-3 | Abasia, Amnesia, Aphonia, Constipation, Impaired Self-care
Adverse event was reported on Apr 27, 2010 by a Female patient taking Haloperidol (View Usage) (Dosage: ) . Location: UNITED STATES , 89 years of age, weighting 110.0 lb, Patient experienced the following unwanted or unexpected effects: abasia, amnesia, aphonia, constipation (What is constipation?), impaired self-care. During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), LYRICA (View Lyrica Review and Lyrica Label ), TRAMADOL (View Tramadol Review and Tramadol Label ). Patient was hospitalized.

6716435-8 | Abasia, Amnesia, Aphonia, Constipation, Impaired Self-care
on Apr 27, 2010 Female patient from UNITED STATES , 89 years of age, weighting 110.0 lb, was treated with Haloperidol (View Usage). Patient had the following side effects: abasia, amnesia, aphonia, constipation (What is constipation?), impaired self-care. Haloperidol dosage: . During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), LYRICA (View Lyrica Review and Lyrica Label ), TRAMADOL (View Tramadol Review and Tramadol Label ). Patient was hospitalized.

6702864-5 | Dementia, Neuroleptic Malignant Syndrome
on Apr 29, 2010 Male patient from UNITED STATES , 83 years of age, was diagnosed with agitation, dementia (What is dementia?) and was treated with Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: dementia (What is dementia?), neuroleptic malignant syndrome. Haloperidol dosage: 2 Mg Tid Po. During the same period patient was treated with OLANZAPINE (10 Mg At Bedtime Po) (View Olanzapine Review and Olanzapine Label ). Patient was hospitalized.

6699770-1 | Cachexia, Delirium, Diarrhoea, Hallucination, Metastases To Liver, Nausea, Pruritus
Patient was taking Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: cachexia, delirium, diarrhoea, hallucination, metastases to liver, nausea (What is nausea?), pruritus on Apr 20, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 73 years of age, was diagnosed with antiemetic supportive care, arthralgia, pain (What is pain?) and. Haloperidol dosage: . During the same period patient was treated with CYCLIZINE (View Cyclizine Review and Cyclizine Label ), DIAMORPHINE (View Diamorphine Review and Diamorphine Label ), LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ). Patient was hospitalized.

6699511-8 | Abasia, Agitation, Dizziness
Adverse event was reported on Apr 27, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: ) was diagnosed with agitation and. Location: UNITED STATES , 85 years of age, weighting 138.9 lb, Patient had the following side effects: abasia, agitation, dizziness (What is dizziness?).

6695373-3 | Akathisia, Dystonia
on Apr 23, 2010 Female patient from UNITED STATES , 32 years of age, weighting 171.0 lb, was diagnosed with agitation and was treated with Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: akathisia, dystonia (What is dystonia?). Haloperidol dosage: 7.5mg Stat Im.

6689389-0 | Anxiety, Blood Alcohol Increased, Depression, Dyspnoea, Emotional Disorder, Eye Rolling, Fatigue, Insomnia, Paranoia
on Apr 19, 2010 Female patient from UNITED STATES , 41 years of age, weighting 162.0 lb, was diagnosed with anxiety (What is anxiety?) and was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), blood alcohol increased, depression (What is depression?), dyspnoea, emotional disorder, eye rolling, fatigue, insomnia, paranoia. Haloperidol dosage: 15 Mg 1 Dose Iv Drip.

6684238-9 | Torticollis
Patient was taking Haloperidol (View Usage). Patient had the following side effects: torticollis on Apr 07, 2010 from SPAIN Additional patient health information: Male patient , child 12 years of age, was diagnosed with tourette's disorder and. Haloperidol dosage: .

6666819-1 | Long Qt Syndrome
Adverse event was reported on Apr 01, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: 2 Mg Bid Po) was diagnosed with agitation and. Location: UNITED STATES , 60 years of age, After Haloperidol was administered, patient had the following side effects: long qt syndrome.

6647606-7 | Electrocardiogram Qt Prolonged
on Mar 23, 2010 Male patient from UNITED STATES , 77 years of age, weighting 164.9 lb, was diagnosed with surgery (What is surgery?) and was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged. Haloperidol dosage: 5 Mg Once Iv. Patient was hospitalized.

6634121-X | Cardiac Murmur, Cyst, Dermal Cyst, Electrocardiogram Qt Prolonged, Malaise, Skin Cancer, Skin Lesion
on Mar 05, 2010 Female patient from UNITED KINGDOM , 57 years of age, was diagnosed with agitation, schizophrenia and was treated with Haloperidol (View Usage). Patient had the following side effects: cardiac murmur, cyst, dermal cyst, electrocardiogram qt prolonged, malaise, skin cancer (What is skin cancer?), skin lesion. Haloperidol dosage: . During the same period patient was treated with CLOZARIL (View Clozaril Review and Clozaril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

6617500-6 | Thrombophlebitis
Patient was taking Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: thrombophlebitis on Feb 26, 2010 from SPAIN Additional patient health information: Male patient , 19 years of age, was diagnosed with obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and. Haloperidol dosage: . During the same period patient was treated with ZELDOX (View Zeldox Review and Zeldox Label ).

6608768-0 | Drooling, Vision Blurred
Adverse event was reported on Feb 24, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: 10mg Po) . Location: UNITED STATES , 51 years of age, weighting 165.0 lb, Patient experienced the following unwanted or unexpected effects: drooling, vision blurred. During the same period patient was treated with OLANZAPINE (View Olanzapine Review and Olanzapine Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), VIT E (View Vit E Review and Vit E Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ).

6608767-9 | Urticaria
on Feb 24, 2010 Male patient from UNITED STATES , 61 years of age, weighting 165.0 lb, was treated with Haloperidol (View Usage). Patient had the following side effects: urticaria. Haloperidol dosage: 5 Mg Po. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), MIRALAX (View Miralax Review and Miralax Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ), BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ).

6608681-9 | Drooling, Extrapyramidal Disorder
on Feb 24, 2010 Male patient from UNITED STATES , 14 years of age, weighting 175.0 lb, was treated with Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: drooling, extrapyramidal disorder. Haloperidol dosage: 5mg Prn Po. During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), CONCERTA (View Concerta Review and Concerta Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6608632-7 | Decreased Eye Contact, Posture Abnormal
Patient was taking Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: decreased eye contact, posture abnormal on Feb 26, 2010 from UNITED STATES Additional patient health information: Female patient , 25 years of age, weighting 148.0 lb, . Haloperidol dosage: 5mg Im (1 Shot). During the same period patient was treated with LIBRIUM (View Librium Review and Librium Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), CIPRO (View Cipro Review and Cipro Label ).

6608630-3 | Eye Disorder, Incontinence, Staring, Unresponsive To Stimuli
Adverse event was reported on Feb 26, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: 5mg Im) . Location: UNITED STATES , 21 years of age, weighting 159.0 lb, Patient had the following side effects: eye disorder, incontinence, staring, unresponsive to stimuli. During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6608035-5 | Limb Discomfort, Muscle Spasms
on Feb 26, 2010 Male patient from UNITED STATES , 25 years of age, weighting 170.0 lb, was treated with Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: limb discomfort, muscle spasms. Haloperidol dosage: 5mg Im. During the same period patient was treated with CARDIZEM (View Cardizem Review and Cardizem Label ), MUTLITVITAMIN (View Mutlitvitamin Review and Mutlitvitamin Label ), ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ).

6607424-2 | Dystonia
on Feb 17, 2010 Female patient from UNITED STATES , 40 years of age, was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: dystonia (What is dystonia?). Haloperidol dosage: . During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE (300/30 Mg) (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), BENTAZEPAM (View Bentazepam Review and Bentazepam Label ).

6593937-9 | Neuroleptic Malignant Syndrome
Patient was taking Haloperidol (View Usage). Patient had the following side effects: neuroleptic malignant syndrome on Feb 15, 2010 from JAPAN Additional patient health information: Male patient , 55 years of age, weighting 138.9 lb, . Haloperidol dosage: . During the same period patient was treated with LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ). Patient was hospitalized.